Teva Pharmaceutical Industries Limited ( TEVJF) - Key Metrics
TEVJF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $4.18 | $0.43 | $1.33 | $1.20 |
| 2025Q3 | $3.91 | $0.38 | $0.32 | $0.20 |
| 2025Q2 | $3.64 | $0.25 | $0.20 | $0.11 |
| 2025Q1 | $3.42 | $0.19 | -$0.09 | -$0.20 |
TEVJF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 18.57 |
| 2025Q3 | ? | 12.87 |
| 2025Q2 | ? | 17.14 |
| 2025Q1 | ? | 19.93 |
TEVJF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -0.63% | ? |
| 2025Q4 | 2.20% | ? |
| 2025Q3 | 1.02% | ? |
| 2025Q2 | 0.64% | ? |
| 2025Q1 | -1.38% | ? |
TEVJF
Price: $28.40
52 week price:
Payout Ratio Range:
Earnings Per Share: 1.21 USD
P/E Ratio: 30.58
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 38.4 billion